YARROW BIOSCIENCE, INC. Earnings Per Share, Basic and Diluted
YARROW BIOSCIENCE, INC. (YARW) reported Earnings Per Share, Basic and Diluted of $0.42 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-06
- YARROW BIOSCIENCE, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was $0.42, a 88.92% decline year-over-year.
- YARROW BIOSCIENCE, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was $0.55, a 86.81% decline year-over-year.
- YARROW BIOSCIENCE, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was $0.59, a 78.85% decline year-over-year.
- YARROW BIOSCIENCE, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was $4.83, a 104.66% increase year-over-year.
- YARROW BIOSCIENCE, INC. earnings per share, basic and diluted for fiscal 2020 was $7.88, a 29.77% decline from fiscal 2019.
- YARROW BIOSCIENCE, INC. earnings per share, basic and diluted for fiscal 2019 was $11.22, a 2.18% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. earnings per share, basic and diluted for fiscal 2018 was $11.47.
- YARROW BIOSCIENCE, INC. earnings per share, basic and diluted for fiscal 2017 was -$5.69.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | $0.42 10-Q · filed 2021-05-06 | |||||||
| 2020-12-31 | $0.55 10-K · filed 2021-03-04 | $7.88 10-K · filed 2021-03-04 | ||||||
| 2020-09-30 | $0.59 10-K · filed 2021-03-04 | $0.15 10-Q · filed 2020-11-05 | $1.99 10-Q · filed 2020-11-05 | |||||
| 2020-06-30 | $4.83 10-K · filed 2021-03-04 | $1.21 10-Q · filed 2020-08-06 | $2.29 10-Q · filed 2020-08-06 | |||||
| 2020-03-31 | $3.79 10-Q · filed 2021-05-06 | $0.95 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | $4.17 10-K · filed 2021-03-04 | -$0.89 10-K · filed 2020-03-03 | $0.48 derived: net income ÷ weighted average shares · filed 2021-03-04 | $2.69 derived: net income ÷ weighted average shares · filed 2021-03-04 | $11.22 10-K · filed 2021-03-04 | -$3.09 10-K · filed 2020-03-03 | ||
| 2019-09-30 | $2.79 10-K · filed 2021-03-04 | -$0.70 10-Q · filed 2019-10-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2020-11-05 | $0.59 10-Q · filed 2020-11-05 | -$2.20 10-Q · filed 2019-10-31 | -$1.44 derived: net income ÷ weighted average shares · filed 2021-03-04 | ||
| 2019-06-30 | $2.36 10-K · filed 2021-03-04 | -$0.69 10-Q · filed 2019-08-01 | $0.35 10-Q · filed 2020-08-06 | -$1.50 10-Q · filed 2019-08-01 | -$1.72 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$2.28 derived: net income ÷ weighted average shares · filed 2021-03-04 | ||
| 2019-03-31 | $1.89 10-K · filed 2021-03-04 | -$0.81 10-Q · filed 2019-05-02 | $13.46 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$8.43 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$5.70 derived: net income ÷ weighted average shares · filed 2021-03-04 | |||
| 2018-12-31 | -$0.76 10-K · filed 2020-03-03 | $4.16 derived: net income ÷ weighted average shares · filed 2021-03-04 | -$14.15 derived: net income ÷ weighted average shares · filed 2021-03-04 | $11.47 10-K · filed 2021-03-04 | -$2.37 10-K · filed 2019-02-28 | |||
| 2018-09-30 | -$0.56 10-K · filed 2020-03-03 | -$0.92 derived: net income ÷ weighted average shares · filed 2019-10-31 | -$1.60 10-Q · filed 2019-10-31 | -$2.52 derived: net income ÷ weighted average shares · filed 2020-03-03 | ||||
| 2018-06-30 | -$0.36 10-K · filed 2020-03-03 | -$1.04 10-Q · filed 2019-08-01 | -$1.99 derived: net income ÷ weighted average shares · filed 2020-03-03 | -$3.03 derived: net income ÷ weighted average shares · filed 2020-03-03 | ||||
| 2018-03-31 | -$0.72 10-K · filed 2020-03-03 | -$1.93 derived: net income ÷ weighted average shares · filed 2020-03-03 | -$3.24 derived: net income ÷ weighted average shares · filed 2020-03-03 | -$4.40 derived: net income ÷ weighted average shares · filed 2020-03-03 | ||||
| 2017-12-31 | -$1.80 10-K · filed 2019-02-28 | -$3.40 derived: net income ÷ weighted average shares · filed 2020-03-03 | -$4.61 derived: net income ÷ weighted average shares · filed 2020-03-03 | -$5.69 10-K · filed 2020-03-03 | ||||
| 2017-09-30 | -$1.59 10-K · filed 2019-02-28 | -$2.81 derived: net income ÷ weighted average shares · filed 2018-11-07 | -$3.89 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$1.21 10-K · filed 2019-02-28 | -$2.29 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | -$1.08 10-K · filed 2019-02-28 | -$1.05 10-K · filed 2018-03-28 | ||||||
| 2016-12-31 | -$0.96 10-K · filed 2018-03-28 | -$2.82 10-K · filed 2019-02-28 | ||||||
| 2016-09-30 | -$0.68 10-K · filed 2018-03-28 | |||||||
| 2016-06-30 | -$0.72 10-K · filed 2018-03-28 | |||||||
| 2016-03-31 | -$0.43 10-K · filed 2018-03-28 | |||||||
| 2015-12-31 | -$0.97 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |